These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Steroid therapy and leprosy. Ramu G Indian J Lepr; 1996; 68(2):182-3. PubMed ID: 8835589 [No Abstract] [Full Text] [Related]
23. Cardiovascular system in leprosy. Singh IP; Mehta SR; Gupta CM; Bhate RD Indian J Lepr; 1986; 58(1):69-72. PubMed ID: 3745999 [TBL] [Abstract][Full Text] [Related]
24. The treatment of leprosy with the sulfones. I. Faget's original 22 patients. A thirty-year follow-up on sulfone therapy for leprosy. Jacobson RR; Trautman JR Int J Lepr Other Mycobact Dis; 1971; 39(3):726-37. PubMed ID: 4948221 [No Abstract] [Full Text] [Related]
25. ENL in borderline leprosy. Karat AB; Job CK; Karat S Int J Lepr Other Mycobact Dis; 1967; 35(3):402-3. PubMed ID: 5630364 [No Abstract] [Full Text] [Related]
26. [Local application of promin in ocular manifestations of leprosy (preliminary note)]. Bouzas A Bull Mem Soc Fr Ophtalmol; 1966; 79():200-6. PubMed ID: 6015380 [No Abstract] [Full Text] [Related]
28. [Leprosy in Tunisia]. Barta T Cesk Otolaryngol; 1972 Feb; 21(1):33-7. PubMed ID: 5010378 [No Abstract] [Full Text] [Related]
29. [Quadriplegia, in lepromatous leprosy previously cleared-up, diffuse polyneuritis which appeared in spite of 6 years of follow-up consolidating treatment with Sultirene alone]. Merklen FP; Cottenot F; Pennec J; Vernant JC; Buzacoux J Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):461-2. PubMed ID: 5150887 [No Abstract] [Full Text] [Related]
30. Length of continued treatment of an inactive case of leprosy. Dharmendra Lepr India; 1976 Jul; 48(3):212-6. PubMed ID: 1022967 [No Abstract] [Full Text] [Related]
32. A century of progress in the therapy of leprosy. Karat AB; Ramanujam K Int J Lepr Other Mycobact Dis; 1973; 41(3):382-91. PubMed ID: 4130572 [No Abstract] [Full Text] [Related]
33. [Treatment of leprosy by sulfones and delayed-action sulfonamides: comparison of therapeutic results in 100 cases]. Privat Y; Faye I; Bellossi A Mars Med; 1968; 105(3):276-80. PubMed ID: 5754252 [No Abstract] [Full Text] [Related]
34. Advances in leprosy control in the last 100 years. Bechelli LM Int J Lepr Other Mycobact Dis; 1973; 41(3):285-97. PubMed ID: 4591732 [No Abstract] [Full Text] [Related]
36. Cardiac dysautonomia in lepromatous leprosy. Kale HD; Zawar PC; Chawhan RN; Kulkarni GR Indian J Lepr; 1984; 56(3):563-8. PubMed ID: 6549324 [TBL] [Abstract][Full Text] [Related]
37. [Leprosy and lepers in Marseilles]. Blanc F; Nosny Y Bull Soc Pathol Exot Filiales; 1970; 63(4):417-29. PubMed ID: 5537228 [No Abstract] [Full Text] [Related]
38. Motor conduction velocity studies in patients with leprosy reaction treated with thalidomide and other drugs. Sheskin J; Magora A; Sagher F Int J Lepr Other Mycobact Dis; 1969; 37(4):359-64. PubMed ID: 4918201 [No Abstract] [Full Text] [Related]
39. The promin treatment of leprosy. A progress report. Faget GH; Pogge RC; Johansen FA; Dinan JF; Prejean BM; Eccles CG Int J Lepr Other Mycobact Dis; 1966; 34(3):298-310. PubMed ID: 5950351 [No Abstract] [Full Text] [Related]
40. Clinical stages in sulfone treatment of leprosy. Rodriguez JN Int J Lepr Other Mycobact Dis; 1970; 38(2):199-203. PubMed ID: 4920411 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]